Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
- PMID: 35853867
- PMCID: PMC9295082
- DOI: 10.1038/s41421-022-00435-w
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Conflict of interest statement
We declare that none of the authors have competing financial or non-financial interests related to this study as defined by Nature Portfolio. S.C. is a Founder of EvolveImmune Tx, Cellinfinity Bio, and Chen Consulting, all unrelated to this study. The remaining authors declare no competing interest.
Figures

References
-
- Coronavirus cases by world meters, https://www.worldometers.info/coronavirus/.
-
- Statement on Omicron sublineage BA.2, https://www.who.int/news/item/22-02-2022-statement-on-omicron-sublineage... (2022).
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous